CNDO-109-AANK for AML in First Complete Remission (CR1)

Clinical trial NCT01520558 · UNKNOWN

Trial details

NCT number: NCT01520558
Sponsor: Coronado Biosciences, Inc.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2012-12-01
Primary completion: 2016-03-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.